AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 13 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,420,000 | -93.4% | 175,000 | -93.0% | 0.39% | -88.1% |
| Q3 2020 | $36,609,000 | +80.7% | 2,485,327 | +148.5% | 3.29% | +86.7% |
| Q4 2019 | $20,260,000 | +176.0% | 1,000,000 | 0.0% | 1.76% | +21.0% |
| Q1 2017 | $7,340,000 | +2.1% | 1,000,000 | -59.3% | 1.46% | -29.2% |
| Q2 2016 | $7,192,000 | +0.1% | 2,457,144 | 0.0% | 2.06% | -20.2% |
| Q1 2016 | $7,187,000 | +16.7% | 2,457,144 | 0.0% | 2.58% | -0.2% |
| Q4 2015 | $6,160,000 | -10.9% | 2,457,144 | 0.0% | 2.58% | -5.5% |
| Q3 2015 | $6,917,000 | +19.0% | 2,457,144 | +26.6% | 2.74% | +20.7% |
| Q2 2015 | $5,812,000 | -31.7% | 1,941,144 | 0.0% | 2.27% | -39.5% |
| Q1 2015 | $8,511,000 | -4.2% | 1,941,144 | -21.9% | 3.75% | -12.4% |
| Q4 2014 | $8,883,000 | +12.2% | 2,485,576 | +0.5% | 4.28% | +25.8% |
| Q3 2014 | $7,917,000 | – | 2,474,076 | – | 3.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |